FDA approves only vaccine Penbraya for treatment of meningococcal disease in adolescents
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Authorisation will help protect adults 60 years of age and older in 30 European countries* from RSV disease for the first time
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Subscribe To Our Newsletter & Stay Updated